4SC-202 tosylate
CAS No. | 1186222-89-8 | Cat. No. | BCP25159 |
Name | 4SC-202 tosylate | ||
Synonyms | 4SC202 tosylate;4SC 202 tosylate;Domatinostat tosylate; | ||
Formula | C30H29N5O6S2 | M. Wt | 619.71 |
Description | 4SC-202 is an orally bioavailable benzamide and inhibitor of human class I histone deacetylases (HDACs) isoenzymes 1, 2 and 3, with potential antineoplastic activity. HDAC inhibitor 4SC-202 selectively binds to and inhibits class I HDACs leading to an accumulation of highly acetylated histones. This may result in an induction of chromatin remodeling, the selective transcription of tumor suppressor genes, and the tumor suppressor protein-mediated inhibition of tumor cell division and eventually the induction of tumor cell apoptosis. This may inhibit tumor cell proliferation in susceptible tumor cells. HDACs, upregulated in many tumor types, are a class of enzymes that deacetylate chromatin histone proteins. | ||
Pathways | Cell Cycle/DNA Damage Epigenetics | ||
Targets | HDAC |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.